African health sciences
-
African health sciences · Jun 2019
Case ReportsRectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report.
Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding.